Edition:
United States

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

18.59USD
23 Apr 2018
Change (% chg)

$0.06 (+0.32%)
Prev Close
$18.53
Open
$18.59
Day's High
$18.59
Day's Low
$18.59
Volume
113
Avg. Vol
6,773
52-wk High
$21.71
52-wk Low
$5.70

Chart for

About

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $140.58
Shares Outstanding(Mil.): 7.50
Dividend: --
Yield (%): --

Financials

  ACER.OQ Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -1.94 -- --
ROI: -116.89 -0.74 13.19
ROE: -233.64 -2.80 15.00

BRIEF-Acer Therapeutics Q4 Loss Per Share $0.63

* ACER THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 07 2018

BRIEF-Acer Therapeutics Q3 loss per share $1.09

* Acer Therapeutics reports third quarter 2017 financial results and provides corporate update

Nov 13 2017

Competitors

Earnings vs. Estimates